Many people begin their research by asking, What is a prostate cancer. Learning the answer helps build a clearer picture of how this disease develops and why screening matters. While many cases remain localised and slow-growing, untreated cancer cells may spread to other parts of the body over time. Many readers trying to understand the condition often search for what is a prostate cancer. To gain clarity about how it begins and what it means for overall health. Let’s take a closer look at prostate cancer, its causes, symptoms, and available care options.
On the table
What is the prostate?
The prostate is a small reproductive gland located in the male body. Located below the bladder and surrounds the tube that carries urine and semen out of the body. Because of its location, prostate health influences urinary and reproductive health.
What are the functions of the prostate?
One of the main functions of the prostate is to produce a nourishing fluid that combines with sperm from the testes to create semen. The fluid protects and transfers sperm during ejaculation. Understanding the function of the prostate gland is important when learning about prostate health, as conditions such as enlargement, inflammation, or cancer can affect normal bodily processes. Any abnormal changes or growth in this gland may lead to urinary symptoms or reproductive concerns and should be evaluated by a physician.
What is a prostate cancer?
The cancer that develops in the prostate is a prostate cancer. It is a small gland located in front of the rectum and below the bladder. This gland is part of the reproductive system in individuals assigned male at birth. It plays an important role in producing the fluid that forms part of semen. When cancer occurs, cells within the prostate begin to grow uncontrollably. They form abnormal tissue that may remain confined to the gland or progress over time.
In many cases, prostate cancer grows slowly and does not spread beyond the prostate, which is why early monitoring and screening can be effective. However, if left untreated, cancerous cells may spread to nearby tissues or other parts of the body, such as bones or lymph nodes. This potential progression highlights the importance of awareness, regular medical consultation, and diagnosis. When exploring information about symptoms, risk factors, or treatment options, people frequently revisit the question of what is a prostate cancer as a starting point for informed decision-making and proactive health management.
What are the causes of prostate cancer?
Prostate cancer begins when the DNA in healthy prostate cells changes. These changes disrupt normal cell growth. As a result, cells start dividing abnormally. The exact causes are still not fully known. However, research has identified genetic mutations and key risk factors linked to the disease. Understanding these cancer causes can support awareness and early detection.
Genetics behind prostate cancer
Prostate cancer is linked to genetic changes that affect cell growth and function. It occurs when DNA mutations cause cells to grow abnormally. These changes often involve genes that control cell division.
Proto-oncogenes normally support healthy growth, but mutations can turn them into oncogenes that drive uncontrolled cell multiplication. Tumour suppressor genes usually stop damaged cells from growing. When they fail, abnormal cells can survive and build up.
Most mutations develop during a person’s lifetime and are not inherited. They may occur randomly or be influenced by biological or environmental factors. A smaller number of cases involve inherited gene changes, including those affecting DNA repair or tumour control.
What are the risk factors?
Data from the Centers for Disease Control and Prevention shows that about 13% of people in the United States develop prostate cancer in their lifetime. Around 2% to 3% die from the disease. Risk is not equal for everyone, though. A range of demographic, lifestyle, and environmental influences can affect the likelihood of developing the disease.
Figures reported by the American Cancer Society show that most cancer diagnoses occur in individuals over the age of 65. The condition is uncommon in those younger than 40, but the probability of diagnosis rises noticeably after age 50.
What are the other factors
1. Body Weight
Obesity has not been consistently shown to raise the overall likelihood of developing prostate cancer. However, some research suggests it may be associated with a higher chance of being diagnosed with more aggressive forms of the disease.
2. Smoking
Current evidence does not show a definite connection between smoking and developing cancer in the prostate. That said, some studies indicate that smoking may increase the risk of death from the condition. Smoking is also known to raise the risk of several other cancers.
3. Chemical Exposure
Exposure to certain chemicals may influence the risk. Research suggests firefighters could encounter substances linked to increased risk. Exposure to Agent Orange, a chemical used during the Vietnam War, has also been associated with a higher risk.
4. Inflammation
Inflammation of the prostate, known as prostatitis, is frequently observed in cancerous prostate tissue samples. While its direct role in causing prostate cancer remains unconfirmed, it continues to be studied as a possible risk factor. Researchers are also examining whether infections that cause prostate inflammation, including sexually transmitted infections such as gonorrhea or chlamydia, might contribute to increased cancer risk.
How common is prostate cancer?
In the U.S., prostate cancer ranks as the second most common cancer among people with prostates after skin cancer. After lung cancer, it accounts for the next highest number of cancer-related deaths. According to the American Cancer Society, about 1 in 44 people die from prostate cancer, although most individuals diagnosed with the disease survive. More than 3.3 million people currently living in the U.S. have received a prostate cancer diagnosis at some point in their lives.
Estimates indicate that roughly 313,780 people in the U.S. will be diagnosed with prostate cancer in 2025, and 35,770 deaths are expected from the disease. Encouragingly, survival outcomes have improved over recent decades. The five-year survival rate for localized prostate cancer is currently 100 percent, while the five-year survival rate for cancer that has spread to other parts of the body is about 37 percent.
What are the symptoms of prostate cancer?
Prostate cancer symptoms can vary from person to person, and some individuals may not notice any signs before diagnosis. When symptoms do occur, they are often related to changes in urinary or pelvic function. Possible symptoms include:
- Trouble starting urination
- Weak or interrupted urine stream
- Needing to urinate more often, particularly at night
- Difficulty emptying the bladder completely
- Pain or burning during urination
- Blood in urine or semen
- Ongoing discomfort in the lower back, pelvis, or hips
- Pain during ejaculation
It is important to remember that these symptoms can also be linked to other health conditions. However, medical advice should be sought if any of these signs appear
Also, click here to read more about: Male Urinary Tract Infection Symptoms
What are the diagnosis and treatment options
Prostate Cancer Diagnosis
Prostate cancer diagnosis typically begins with routine screening or medical evaluation when symptoms or risk factors are present. Several screening tests and diagnostic methods help doctors detect and confirm the condition:
- PSA (Prostate-Specific Antigen) Test: The PSA is a common blood test for prostate cancer screening that measures PSA levels. Elevated levels could lead to additional follow-up.
- Digital Rectal Examination (DRE): A clinical exam used to assess the prostate gland for unusual size, shape, or changes in texture.
- Imaging Tests: Techniques such as MRI or ultrasound help identify suspicious areas within the prostate.
- Prostate Biopsy: A diagnostic procedure in which prostate tissue samples are examined microscopically. This is the most reliable method for confirming prostate cancer.
Early prostate cancer detection through screening and diagnostic testing can improve management outcomes.
Prostate Cancer Treatment Options
The treatment depends on the stage of the disease, tumour features, overall health, and patient preferences. Common treatment approaches include:
- Active Surveillance: Monitoring slow-growing prostate cancer through regular testing and follow-up.
- Prostate Surgery: Surgical removal of the prostate gland to treat localized cancer.
- Radiation Therapy: Targeted radiation treatment to destroy cancer cells.
- Hormone Therapy: Treatment that blocks or reduces hormones that promote cancer growth.
- Advanced or Targeted Therapies: Additional treatment options may be used depending on disease progression.
A personalized treatment plan is developed after careful discussion between patients and healthcare providers.
Conclusion
Prostate cancer awareness is important for early recognition and timely care. Understanding the prostate, potential symptoms, and risk factors helps support informed health decisions. Screening and medical consultation play a key role in detection, and several treatment options are available depending on individual needs. Staying informed encourages proactive and confident management of prostate health.
FAQs
1. What is the main cause of prostate cancer?
Prostate cancer develops when genetic changes cause cells to grow uncontrollably, with risk influenced by age, family history, inherited mutations, and racial background. Although the exact cause is unknown, lifestyle and environmental factors such as obesity, diet, smoking, inflammation, infections, and chemical exposure may also increase risk.
2. Who mostly gets prostate cancer?
Age is the most common risk factor for this cancer, with risk increasing as men grow older. Higher risk is also seen in individuals with a family history of the disease or those of African American background.
3. At what age does prostate cancer start?
Prostate cancer is the most common non-skin cancer in men and is typically associated with older age, with a median diagnosis age of 68 years. However, about 10% of new cases in the United States occur in men aged 55 or younger.